Spontaneous neutrophil migration patterns during sepsis after major burns

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Jones, Caroline N ^a,b,c   Moore, Molly ^a   Dimisko, Laurie ^a,b   Alexander, Andrew ^a   Ibrahim, Amir ^a,c,d   Hassell, Bryan A ^b,e   Warren, H Shaw ^a,c   Tompkins, Ronald G ^a   Fagan, Shawn P ^a   Irimia, Daniel ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Center for Engineering in Medicine   (United States)

^c SHRINERS HOSPITALS FOR CHILDREN   (United States)

^d AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^e HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BURN; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE MIGRATION; MALE; MICROFLUIDIC ANALYSIS; MICROFLUIDICS; NEUTROPHIL; PHENOTYPE; RETROSPECTIVE STUDY; SEPSIS; ADOLESCENT; CASE CONTROL STUDY; COMPLICATION; IMMUNOLOGY; IMMUNOPATHOLOGY; LEUKOCYTE DISORDER; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BURNS; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNE SYSTEM DISEASES; LEUKOCYTE DISORDERS; MALE; MICROFLUIDIC ANALYTICAL TECHNIQUES; MIDDLE AGED; PHENOTYPE; RETROSPECTIVE STUDIES; SEPSIS; YOUNG ADULT;

EID: 84918566237     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114509     Document Type: Article

References (52)

1. D'Avignon LC, Hogan BK, Murray CK, Loo FL, Hospenthal DR, et al. (2010) Contribution of bacterial and viral infections to attributable mortality in patients with severe burns: An autopsy series. Burns 36: 773-779.
2. Williams FN, Herndon DN, Hawkins HK, Lee JO, Cox RA, et al. (2009) The leading causes of death after burn injury in a single pediatric burn center. Crit Care 13: R183.
3. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, et al. (2001) Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310.
4. Kumar A, Ellis P, Arabi Y, Roberts D, Light B, et al. (2009) Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136: 1237-1248.
5. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, et al. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29: 530-538.
6. Fournier PE, Drancourt M, Colson P, Rolain JM, La SB, et al. (2013) Modern clinical microbiology: New challenges and solutions. NatRevMicrobiol 11: 574-585.
7. Seng P, Rolain JM, Fournier PE, La SB, Drancourt M, et al. (2010) MALDI-TOF-mass spectrometry applications in clinical microbiology. FutureMicrobiol 5: 1733-1754.
8. Branski LK, Al-Mousawi A, Rivero H, Jeschke MG, Sanford AP, et al. (2009) Emerging infections in burns. SurgInfect(Larchmt) 10: 389-397.
9. Bernard GR, Vincent JL, Laterre PF, Larosa SP, Dhainaut JF, et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. NEnglJMed 344: 699-709.
10. Jeschke MG, Finnerty CC, Kulp GA, Kraft R, Herndon DN (2013) Can we use C-reactive protein levels to predict severe infection or sepsis in severely burned patients? IntJBurns Trauma 3: 137-143.
11. Fitrolaki DM, Dimitriou H, Kalmanti M, Briassoulis G (2013) CD64-Neutrophil expression and stress metabolic patterns in early sepsis and severe traumatic brain injury in children. BMCPediatr 13: 31.
12. Fjaertoft G, Hakansson LD, Pauksens K, Sisask G, Venge P (2007) Neutrophil CD64 (FcgammaRI) expression is a specific marker of bacterial infection: A study on the kinetics and the impact of major surgery. ScandJInfectDis 39: 525-535.
13. Karzai W, Oberhoffer M, Meier-Hellmann A, Reinhart K (1997) Procalcitonin-a new indicator of the systemic response to severe infections. Infection 25: 329-334.
14. Oberhoffer M, Karzai W, Meier-Hellmann A, Bogel D, Fassbinder J, et al. (1999) Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-alpha and interleukin-6 in patients with sepsis. Crit Care Med 27: 1814-1818.
15. Pascual C, Karzai W, Meier-Hellmann A, Oberhoffer M, Horn A, et al. (1998) Total plasma antioxidant capacity is not always decreased in sepsis. Crit Care Med 26: 705-709.
16. Tavares-Murta BM, Zaparoli M, Ferreira RB, Silva-Vergara ML, Oliveira CH, et al. (2002) Failure of neutrophil chemotactic function in septic patients. Crit Care Med 30: 1056-1061.
17. Danikas DD, Karakantza M, Theodorou GL, Sakellaropoulos GC, Gogos CA (2008) Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression. ClinExpImmunol 154: 87-97.
18. Parihar A, Parihar MS, Milner S, Bhat S (2008) Oxidative stress and anti-oxidative mobilization in burn injury. Burns 34: 6-17.
19. Kasten KR, Muenzer JT, Caldwell CC (2010) Neutrophils are significant producers of IL-10 during sepsis. BiochemBiophysResCommun 393: 28-31.
20. Bjerknes R, Vindenes H (1989) Neutrophil dysfunction after thermal injury: Alteration of phagolysosomal acidification in patients with large burns. Burns 15: 77-81.
21. Boyden S (1962) The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med 115: 453-466.
22. Li Jeon N, Baskaran H, Dertinger SK, Whitesides GM, Van De Water L, et al. (2002) Neutrophil chemotaxis in linear and complex gradients of interleukin-8 formed in a microfabricated device. Nat Biotechnol 20: 826-830.
23. Abhyankar VV, Lokuta MA, Huttenlocher A, Beebe DJ (2006) Characterization of a membrane-based gradient generator for use in cell-signaling studies. Lab Chip 6: 389-393.
24. Irimia D, Liu SY, Tharp WG, Samadani A, Toner M, et al. (2006) Microfluidic system for measuring neutrophil migratory responses to fast switches of chemical gradients. Lab Chip 6: 191-198.
25. Keenan TM, Folch A (2008) Biomolecular gradients in cell culture systems. Lab Chip 8: 34-57.
26. Lin F, Nguyen CM, Wang SJ, Saadi W, Gross SP, et al. (2005) Neutrophil migration in opposing chemoattractant gradients using microfluidic chemotaxis devices. Ann Biomed Eng 33: 475-482.
27. Saadi W, Rhee SW, Lin F, Vahidi B, Chung BG, et al. (2007) Generation of stable concentration gradients in 2D and 3D environments using a microfluidic ladder chamber. Biomed Microdevices 9: 627-635.
28. Irimia D, Balazsi G, Agrawal N, Toner M (2009) Adaptive-control model for neutrophil orientation in the direction of chemical gradients. Biophys J 96: 3897-3916.
29. Sackmann EK, Berthier E, Young EW, Shelef MA, Wernimont SA, et al. (2012) Microfluidic kit-on-alid: A versatile platform for neutrophil chemotaxis assays. Blood 120: E45-e53.
30. Ambravaneswaran V, Wong IY, Aranyosi AJ, Toner M, Irimia D (2010) Directional decisions during neutrophil chemotaxis inside bifurcating channels. Integr Biol (Camb) 2: 639-647.
31. Irimia D, Charras G, Agrawal N, Mitchison T, Toner M (2007) Polar stimulation and constrained cell migration in microfluidic channels. Lab Chip 7: 1783-1790.
32. Butler KL, Ambravaneswaran V, Agrawal N, Bilodeau M, Toner M, et al. (2010) Burn injury reduces neutrophil directional migration speed in microfluidic devices. PLoS One 5: E11921.
33. Bjerknes R, Vindenes H, Laerum OD (1990) Altered neutrophil functions in patients with large burns. Blood Cells 16: 127-141.
34. De Chalain TM, Bracher M, Linley W, Gerneke D, Hickman R (1994) Cytoskeletal actin: The influence of major burns on neutrophil structure and function. Burns 20: 416-421.
35. Hietbrink F, Koenderman L, Althuizen M, Pillay J, Kamp V, et al. (2013) Kinetics of the innate immune response after trauma: Implications for the development of late onset sepsis. Shock 40: 21-27.
36. Kim Y, Goldstein E, Lippert W, Brofeldt T, Donovan R (1989) Polymorphonuclear leucocyte motility in patients with severe burns. Burns 15: 93-97.
37. Solomkin JS, Nelson RD, Chenoweth DE, Solem LD, Simmons RL (1984) Regulation of neutrophil migratory function in burn injury by complement activation products. Ann Surg 200: 742-746.
38. Warden GD, Mason AD Jr., Pruitt BA Jr. (1975) Suppression of leukocyte chemotaxis in vitro by chemotherapeutic agents used in the management of thermal injuries. Ann Surg 181: 363-369.
39. Kurihara T, Jones CN, Yu YM, Fischman AJ, Watada S, et al. (2013) Resolvin D2 restores neutrophil directionality and improves survival after burns. Faseb J 27: 2270-2281.
40. Warden GD, Mason AD Jr., Pruitt BA Jr. (1974) Evaluation of leukocyte chemotaxis in vitro in thermally injured patients. J Clin Invest 54.
41. Hamza B, Wong E, Patel S, Cho H, Martel J, et al. (2014) Retrotaxis of human neutrophils during mechanical confinement inside microfluidic channels. IntegrBiol(Camb) 6: 175-183.
42. Irimia D (2010) Microfluidic technologies for temporal perturbations of chemotaxis. Annu Rev Biomed Eng 12: 259-284.
43. Anand D, Das S, Bhargava S, Srivastava LM, Garg A, et al. (2014) Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome: A prospective, observational, cohort study. J Crit Care.
44. Fan H, Zhao Y, Zhu JH, Song FC (2014) Urine neutrophil gelatinase-associated lipocalin in septic patients with and without acute kidney injury. Ren Fail 36: 1399-1403.
45. Heit B, Robbins SM, Downey CM, Guan Z, Colarusso P, et al. (2008) PTEN functions to 'prioritize' chemotactic cues and prevent 'distraction' in migrating neutrophils. NatImmunol 9: 743-752.
46. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, et al. (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464: 104-107.
47. Kolaczkowska E, Kubes P (2013) Neutrophil recruitment and function in health and inflammation. NatRevImmunol 13: 159-175.
48. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, et al. (2001) Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. AmJRespirCrit Care Med 164: 396-402.
49. Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, et al. (2000) Protection from septic shock by neutralization of macrophage migration inhibitory factor. NatMed 6: 164-170.
50. Kuster H, Weiss M, Willeitner AE, Detlefsen S, Jeremias I, et al. (1998) Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet 352: 1271-1277.
51. Martensson J, Bell M, Oldner A, Xu S, Venge P, et al. (2010) Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med 36: 1333-1340.
52. Yali G, Jing C, Chunjiang L, Cheng Z, Xiaoqiang L, et al. (2014) Comparison of pathogens and antibiotic resistance of burn patients in the burn ICU or in the common burn ward. Burns 40: 402-407.